Category: Conferences

Search News
Categories
Archives
Blood test predicts chemotherapy resistance in prostate cancer

11th November 2021

Research conducted at Barts Cancer Institute (BCI), Queen Mary University of London, indicates that regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with a drug called docetaxel. Ms Caitlin Davies, a PhD student at BCI, presented the findings from her PhD research at the National Cancer Research Institute (NCRI) Festival, which is taking place from 8-12th November 2021.

Read more

New class of drug reduces risk of death in bladder cancer

15th February 2021

A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Professor Tom Powles from Barts Cancer Institute, Queen Mary University of London and Barts Health NHS Trust.

Read more

London Pancreas Workshop 2020

30th September 2020

On 11th September 2020, Professors Hemant Kocher and Nick Lemoine hosted the eighth London Pancreas Workshop (LPW) – a forum for state-of-the-art clinical and basic research in pancreatic cancer. In a first for the biennial event, this year’s LPW took place online with pre-recorded speaker presentations and live, interactive Q&A sessions.

Read more

Immunotherapy for advanced bladder cancer

29th May 2020

An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.

Read more

Prof Manchanda awarded prestigious oration

16th December 2019

Professor Ranjit Manchanda delivered the Shyam Agarwal Memorial Oration at the Indian Society of Cancer Genetics Conference on 15 December.

Read more

ASH 2019

16th December 2019

Once again this December, researchers from Barts Cancer Institute (BCI)’s Centre for Haemato-Oncology made the trip to the American Society of Hematology Annual Meeting and Exposition, which this year took place in Orlando, Florida.

Read more

Search News
Categories
Archives